Drug Shortage Report for ACH-APIXABAN
| Report ID | 212848 |
| Drug Identification Number | 02487721 |
| Brand name | ACH-APIXABAN |
| Common or Proper name | APIXABAN |
| Company Name | ACCORD HEALTHCARE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | APIXABAN |
| Strength(s) | 5MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 60 180 |
| ATC code | B01AF |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-12-08 |
| Estimated end date | 2024-03-14 |
| Actual end date | 2024-03-15 |
| Shortage status | Resolved |
| Updated date | 2024-03-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.